Ki-67 is a prognostic biomarker of survival after radiofrequency ablation of liver malignancies - Wikidata - wikimedia - TriplyDB

Ki-67 is a prognostic biomarker of survival after radiofrequency ablation of liver malignancies

Ki-67 is a prognostic biomarker of survival after radiofrequency ablation of liver malignancies

http://www.wikidata.org/entity/Q34003699

about

Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis Multimodality imaging to assess immediate response to irreversible electroporation in a rat liver tumor model.18F-FDG PET/CT Is an Immediate Imaging Biomarker of Treatment Success After Liver Metastasis Ablation Feasibility of a Modified Biopsy Needle for Irreversible Electroporation Ablation and Periprocedural Tissue Sampling.Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center.Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness.Ki 67 is an independent predictive biomarker of cancer specific and local recurrence-free survival after lung tumor ablation.Hepatic Thermal Ablation: Effect of Device and Heating Parameters on Local Tissue Reactions and Distant Tumor Growth.Thermal Ablation in the Management of Colorectal Cancer Patients with Oligometastatic Liver Disease.Colorectal Cancer Liver Metastases: Biopsy of the Ablation Zone and Margins Can Be Used to Predict Oncologic Outcome.High expression of Ki-67 is an independent favorable prognostic factor for esophageal small cell carcinoma.Evaluation of YO-PRO-1 as an early marker of apoptosis following radiofrequency ablation of colon cancer liver metastases.Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases.Elevated Ki-67 labeling index in 'synchronous liver metastases' of well differentiated enteropancreatic neuroendocrine tumor.Micropapillary and/or Solid Histologic Subtype Based on Pre-Treatment Biopsy Predicts Local Recurrence After Thermal Ablation of Lung Adenocarcinoma.Immediate Post-ablation FDG-injection and corresponding Standardized Uptake Value is a Surrogate Biomarker of Local Tumor Progression after Thermal Ablation of Colorectal Carcinoma Liver Metastases.Diagnostic yield of a biopsy performed immediately after lung radiofrequency ablation.

P2860

Q26784351-6AB42723-2674-44B4-BEAA-2BF006A13D74 Q30415023-FA0F84F7-05F2-4915-9E39-3EBFF077CEAA Q33835460-FAB665D3-E0BE-44A0-ACD6-EA504F88DCF4 Q33865049-D19C0896-150A-4A1F-A4D4-7DE72383551D Q34003713-E684DDA5-2874-4BC0-9647-FBBD698E8AEA Q36524431-D799E274-D54C-4A5A-BED1-941BED016370 Q36946481-2A54242C-6706-4523-8635-56C61F35AB6A Q38125094-C2743ADC-741F-465A-A272-95C83202B80F Q38412660-B61400A7-0709-43AD-8214-3544A2D1F4D2 Q38726773-D9E41D76-3232-4145-A7AA-21BFFD534A69 Q38787064-F301F917-E2C2-4D84-B866-889C450A85AC Q41548862-4855FD86-7895-4AA3-8583-24666EC83481 Q41934918-05AF32FF-A510-4E07-948C-75C5668BD2A7 Q42371613-F560BCFD-5AC0-4385-AB82-F552557E9A75 Q43629579-9FADB604-C0C3-4FCD-99CC-FE64BCEE3417 Q48301301-BC1FD86E-AEF0-4A94-A66A-3C951A09A27D Q50036604-EAE08BD7-7FFD-426D-9D4C-316AE0C12B40 Q53084428-10EC04DC-58C3-40AC-B809-3C13F65CA540

P2860

Ki-67 is a prognostic biomarker of survival after radiofrequency ablation of liver malignancies

http://www.wikidata.org/entity/Q34003699

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Ki-67 is a prognostic biomarke ...... ablation of liver malignancies

@ast

Ki-67 is a prognostic biomarke ...... ablation of liver malignancies

@en

Ki-67 is a prognostic biomarke ...... ablation of liver malignancies

@nl

type

label

Ki-67 is a prognostic biomarke ...... ablation of liver malignancies

@ast

Ki-67 is a prognostic biomarke ...... ablation of liver malignancies

@en

Ki-67 is a prognostic biomarke ...... ablation of liver malignancies

@nl

prefLabel

Ki-67 is a prognostic biomarke ...... ablation of liver malignancies

@ast

Ki-67 is a prognostic biomarke ...... ablation of liver malignancies

@en

Ki-67 is a prognostic biomarke ...... ablation of liver malignancies

@nl

P1433

Q34003699-BA0E5E73-16CF-49B4-80A3-88D5195E251F

P1476

Q34003699-B1B6CA41-9F2A-4BE2-B060-7A9458A2DADF

P2093

Q34003699-0E904C0B-4822-4906-80DE-140F4E400E0C

Q34003699-17F4DC2B-36A6-4309-A5F9-C54866144EBB

Q34003699-39D0DC3D-5552-4B8D-859D-C8C76BE78ED6

Q34003699-585BD9A2-D432-4838-BE73-A0285037DAE8

Q34003699-744D6EE9-2011-49CE-A490-93777C428FAF

Q34003699-9E658CF4-B4F6-4894-9096-67B986A19D51

Q34003699-A22059EE-8E26-43FE-9C40-81A9C7D0DF21

Q34003699-AA2FA5C8-3544-46D2-B272-A69CA0066C70

Q34003699-BE7AB15D-DE0E-4BD8-947C-257691A0E7A9

Q34003699-CFAD21C9-E7B4-470A-B2A2-59FF787D6EF0

P2860

Q34003699-02152D04-94E7-42F1-9FC5-FCD07DAB72FC

Q34003699-05A3CD53-C8AF-4352-A23B-6B550A236BC6

Q34003699-065810BA-79D1-4001-B589-7C5B35FC94D2

Q34003699-1A38A5DA-AA9C-4226-852F-778C0E844355

Q34003699-1F637ABE-1670-41FF-BB11-9E163CF0C7FD

Q34003699-3B085985-AB7A-4F03-96CC-34834763F6B2

Q34003699-410281B5-497F-4097-93D4-9E5CFA358530

Q34003699-47D9095B-233A-4578-ABFC-202C3B3E302C

Q34003699-4F1AB0C2-F3F5-4952-ACB1-65ED604DFB7D

Q34003699-65A5318D-6E3B-4205-A8E1-64870ED43665

P2888

Q34003699-D9C342D5-D99E-4450-9A0B-41825923722E

P304

Q34003699-5298D206-A425-4B2E-8BFA-BE1ABC0CDDA3

P31

Q34003699-96583632-3741-4F51-98CA-8AC913F844AC

P356

Q34003699-F485806A-47A4-4BC6-A6C6-69F30CAD5801

P433

Q34003699-AD7416AF-4BCA-4CD1-B9E0-766D4A622D3A

P478

Q34003699-1FF335CA-FCE8-4C71-A085-0D97263CB5DE

P50

Q34003699-2A3DADC8-2E4E-4801-9ADB-F060E78EA429

P577

Q34003699-0B6D33E1-440C-4CCD-A76A-D63EA325F9CA

P6179

Q34003699-26828836-CA77-42AC-A8E1-3E1896B96D52

P698

Q34003699-B7DC0D71-3A72-40CA-B953-06109107B2AE

P921

Q34003699-205C794E-560F-4326-ABDD-BCD25697B8F7

P932

Q34003699-6A8171AE-0919-44F6-BF2B-F02DCA645C1A

P356

S10434-012-2461-9

P1433

Annals of Surgical Oncology

P1476

Ki-67 is a prognostic biomarke ...... ablation of liver malignancies

@en

P2093

Ann M Covey

http://www.w3.org/2001/XMLSchema#string

Constantinos T Sofocleous

http://www.w3.org/2001/XMLSchema#string

David S Klimstra

http://www.w3.org/2001/XMLSchema#string

Elena N Petre

http://www.w3.org/2001/XMLSchema#string

Lawrence Schwartz

http://www.w3.org/2001/XMLSchema#string

Lydia M Petrovic

http://www.w3.org/2001/XMLSchema#string

Lynn A Brody

http://www.w3.org/2001/XMLSchema#string

Mithat Gonen

http://www.w3.org/2001/XMLSchema#string

Nancy E Kemeny

http://www.w3.org/2001/XMLSchema#string

Ronald P Dematteo

http://www.w3.org/2001/XMLSchema#string

P2860

Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates

Image-guided tumor ablation: standardization of terminology and reporting criteria

Radiofrequency ablation of liver tumors: a systematic review.

Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer

Biochemical pathways of caspase activation during apoptosis.

Radiofrequency ablation of primary and metastatic liver tumors.

Factors for early tumor recurrence of single small hepatocellular carcinoma after percutaneous radiofrequency ablation therapy.

Treatment efficacy of radiofrequency ablation of 338 patients with hepatic malignant tumor and the relevant complications.

Viable tumor tissue adherent to needle applicators after local ablation: a risk factor for local tumor progression

Percutaneous radiofrequency ablation of hepatic colorectal metastases: technique, indications, results, and new promises.

P2888

s10434-012-2461-9

P304

4262-4269

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-012-2461-9

http://www.w3.org/2001/XMLSchema#string

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1024919655

http://www.w3.org/2001/XMLSchema#string

P698

22752375

http://www.w3.org/2001/XMLSchema#string

P921

P932

4122119

http://www.w3.org/2001/XMLSchema#string